Page 2 - Hong Kong (HSI) Pharmaceuticals & Biotech Stocks - Top Gainers Today

UPDATED May 09, 2025

Explore the Hong Kong (HSI) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.

106 companies
CompanyLast Price1D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
1558
YiChang HEC ChangJiang Pharmaceutical
HK$13.020.5%-1.1%HK$11.5bHK$12.60PE22.1xS15.9%0%
1666
Tong Ren Tang Technologies
HK$4.930.8%-12.6%HK$6.3bHK$6.14PE11.3xE8.5%3.9%
2126
JW (Cayman) Therapeutics
HK$1.607.4%-34.2%HK$648.4mHK$2.40PS3.8xS35.4%n/a
2179
Jiangsu Recbio Technology
HK$8.681.0%-5.7%HK$4.1bn/aPS142.8xn/an/a
1521
Frontage Holdings
HK$1.141.8%-7.3%HK$2.3bHK$1.05PE375xE52.3%n/a
1877
Shanghai Junshi Biosciences
HK$14.800.1%17.3%HK$27.1bHK$15.69PS6.6xE42.1%n/a
455
Tianda Pharmaceuticals
HK$0.168.0%-37.7%HK$348.3mn/aPS1.1xn/a0%
2509
Qyuns Therapeutics
HK$11.121.1%-59.0%HK$2.5bn/aPS14.5xn/an/a
575
Regent Pacific Group
HK$0.8912.7%119.8%HK$203.3mn/aPS36.4xn/an/a
9969
InnoCare Pharma
HK$9.650.1%89.2%HK$20.3bHK$10.30PS15.7xE42.5%n/a
1541
ImmuneOnco Biopharmaceuticals (Shanghai)
HK$6.440.8%-55.8%HK$2.6bn/aPS30.7xn/an/a
1312
Kontafarma China Holdings
HK$0.0278.0%-27.0%HK$150.9mn/aPB0.2xn/a0%
3681
SinoMab BioScience
HK$1.300.8%-29.7%HK$1.4bn/aPS652.1xn/an/a
2552
Hua Medicine (Shanghai)
HK$2.120.5%39.5%HK$2.1bn/aPS7.6xn/an/a
2161
JBM (Healthcare)
HK$2.240.4%124.0%HK$1.8bHK$2.42PE11.1xE13.3%4.9%
8225
China Health Group
HK$0.164.0%28.9%HK$155.3mn/aPS5.5xn/an/a
6622
Zhaoke Ophthalmology
HK$1.650.6%5.8%HK$901.1mHK$2.50PS12.1xE10.0%n/a
858
Extrawell Pharmaceutical Holdings
HK$0.0553.8%71.9%HK$131.5mn/aPE0.7xn/an/a
9939
Kintor Pharmaceutical
HK$1.260.8%12.5%HK$547.1mn/aPS101.9xn/an/a
239
Pak Fah Yeow International
HK$2.310.4%3.6%HK$719.9mn/aPE9.2xn/a8.7%
8158
China Regenerative Medicine International
HK$0.400%100.0%HK$121.7mn/aPE6.9xn/an/a
2348
Dawnrays Pharmaceutical (Holdings)
HK$1.160%-4.1%HK$1.7bn/aPE2.9xn/a5.4%
1349
Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd
HK$2.640%17.9%HK$6.9bn/aPE63.6xn/a2.4%
2496
Wuhan YZY Biopharma
HK$4.500%-39.6%HK$872.3mn/aPS7.5xn/an/a
Page 2 of 5